Anjac Health & Beauty continues its offensive external growth strategy and consolidates its cosmetics offer. The Californian company could be a key asset for the French group to expand in several growth markets, including Clean Beauty.
"We are pleased to expand our know-how in such a dynamic and influential region for our key markets. Great opportunities and synergies are opening up to the Group,” said Aurélien Chaufour, General Manager of Anjac Health & Beauty.
The business of Cosmetix West (about US$40 million in 2018), which develops skincare products for numerous indie and historic brands in North America, allows Anjac Health & Beauty to strengthen its position in the cosmetics and dermo-cosmetics sectors, in addition to the offer of the group’s other entities in this sector: Sicaf, Shadeline, Eurowipes and Feltor Laboratories. This acquisition also provides the group with new opportunities to expand its product offer to address new consumer expectations that have become essential for cosmetic brands, such as Clean Beauty - in other words, transparent, minimalist and efficient cosmetic solutions that emphasize naturalness - as well as men’s grooming, or Japanese-inspired cosmetics known as “J-Beauty”.
Located in the Los Angeles area, Cosmetix West has acquired an extensive know-how in the formulation, development, manufacture and filling of skin, hair care and hygiene products and fragrances, developed in various galenics. Thanks to its capacity to innovate and adapt, the company has been able to attract many major indie brands to its customers line up.
This is the fifth acquisition in less than two years for Anjac Health & Beauty. This external development strategy allowed the group to double its turnover between 2016 and 2019. Anjac Health & Beauty now includes ten companies and 14 R&D and production sites in the fields of health, hygiene, beauty and nutritional supplements: Innovi, Chemineau, Feltor Laboratories, Shadeline, SICAF, LPEV, Euro Wipes, Aircos, Pascual Cosmetics, and Cosmetix West, for a turnover of 280 million euros expected in 2019.